BMW: Full-Year Auto EBIT Margin and Free Cash Flow Guidance Downgraded on China and Tariffs

We think Bayerische Motoren Werke stock is moderately undervalued.

A BMW logo of the BMW i7 electric car.
Indranil Aditya/NurPhoto via Getty
Securities in This Article
Bayerische Motoren Werke AG
(BMW)

Key Morningstar Metrics for Bayerische Motoren Werke

BMW’s BMW solid third-quarter sales momentum in Europe, the US, and the rest of the world was overshadowed by a downgrade to full-year guidance for auto operating profit margin and free cash flow, attributable to weaker-than-expected performance in China and a higher-than-expected US tariff burden.

Why it matters: The downward revision to BMW’s auto EBIT margin is for the bottom half of its existing guidance, therefore not differing materially from market expectations. The more significant free cash flow downgrade we view as temporary, with most of it expected to be recouped in 2026.

  • BMW has downgraded its full-year EBIT margin guidance to 5%-6% from 5%-7%. A quarter of a percentage point of the downgrade is attributable to the additional tariff burden, largely due to delayed implementation and newly introduced dealer compensation in China, which will offset some of the cost savings we expect to be achieved in China as a result of rightsizing.
  • In addition to weaker margins, the delayed refund of US tariffs from 2025 to 2026 is expected to reduce BMW’s free cash flow by several hundred million dollars. We expect this to be reversed in 2026.

The bottom line: We reduce our fair value estimate for no-moat BMW to EUR 103 from EUR 109 per share.

  • We continue to see BMW as the quality play within the European auto sector. We believe that its achievement of peak capital expenditure in 2025 and the rollout of the Neue Klasse technology across models and powertrains will differentiate BMW from its European peers, supporting above-market volume growth and a faster margin and free cash flow recovery than its peers.

Editor’s Note: This analysis was originally published as a stock note by Morningstar Equity Research.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.

Sponsor Center